If you are wondering whether Exponent is fairly priced or offering value right now, you are in the right place for a clear, ...
Scientific consulting firm Exponent (NASDAQ:EXPO) will be reporting earnings this Thursday after market hours. Here’s what ...
Exponent (EXPO) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.46 per share a year ago. These figures are ...
JP Morgan recently initiated coverage on Exponent with an Overweight/Buy rating, highlighting the firm’s position as a ...
Exponent’s revenue has grown at a CAGR of 6% while EBITDA has at 8%. This has been driven by its fantastic business model and industry tailwinds. Exponent provides highly complex consulting services ...
Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future ...
MENLO PARK, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2025 ended January 2, 2026.